CLINICAL TRIAL: PHASE I TRIAL OF ABRAXANE IN COMBINATION WITH GEMCITABINE IN SOL
CLINICAL TRIAL: PHASE I TRIAL OF ABRAXANE IN COMBINATION WITH GEMCITABINE IN SOL
批准号:
7716859
负责人:
Thomas Stinchcombe
金额:
$0.51万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-02 至 2008-05-31
中文摘要
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得主要资金,
因此可以在其他CRISP条目中表示。列出的机构是
中心,不一定是研究者的机构。
本研究的目的是观察与吉西他滨联合使用时Abraxane的最高剂量。 将测试不同剂量的Abraxane。 给予的吉西他滨量将是标准剂量-未测试不同剂量的吉西他滨。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The purpose of this study is to see the highest amount of Abraxane that can be given with gemcitabine. Different doses of Abraxane will be tested. The amount of gemcitabine that is given will be the standard dose - different doses of gemcitabine are not being tested.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: CISPLATIN/ETOPOSIDE OR CARBOPLATIN/PEMETREXED IN PATIENTS WITH S
-
批准号:7716920
-
项目类别:
-
资助金额:$0.17万
-
财政年份:2008
-
负责人:Thomas Stinchcombe
-
依托单位:
LCCC 0412: PHASE I CARBOPLATIN AND ABRAXANE IN PATIENTS WITH SOLID TUMORS
-
批准号:7625597
-
项目类别:
-
资助金额:$1.43万
-
财政年份:2006
-
负责人:Thomas Stinchcombe
-
依托单位:
PHASE I TRIAL OF ABRAXANE IN COMBINATION WITH GEMCITABINE IN SOLID TUMORS
-
批准号:7625658
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2006
-
负责人:Thomas Stinchcombe
-
依托单位:
LCCC 0412: PHASE I CARBOPLATIN AND ABRAXANE IN PATIENTS WITH SOLID TUMORS
-
批准号:7377549
-
项目类别:
-
资助金额:$9.61万
-
财政年份:2005
-
负责人:Thomas Stinchcombe
-
依托单位:
海外基金